Recurrent PTPRB and PLCG1 mutations in angiosarcoma.

Nat Genet 2014 Apr 16;46(4):376-379. Epub 2014 Mar 16.

Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.

Angiosarcoma is an aggressive malignancy that arises spontaneously or secondarily to ionizing radiation or chronic lymphoedema. Previous work has identified aberrant angiogenesis, including occasional somatic mutations in angiogenesis signaling genes, as a key driver of angiosarcoma. Here we employed whole-genome, whole-exome and targeted sequencing to study the somatic changes underpinning primary and secondary angiosarcoma. We identified recurrent mutations in two genes, PTPRB and PLCG1, which are intimately linked to angiogenesis. The endothelial phosphatase PTPRB, a negative regulator of vascular growth factor tyrosine kinases, harbored predominantly truncating mutations in 10 of 39 tumors (26%). PLCG1, a signal transducer of tyrosine kinases, encoded a recurrent, likely activating p.Arg707Gln missense variant in 3 of 34 cases (9%). Overall, 15 of 39 tumors (38%) harbored at least one driver mutation in angiogenesis signaling genes. Our findings inform and reinforce current therapeutic efforts to target angiogenesis signaling in angiosarcoma.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032873PMC
April 2014
54 Reads
29.352 Impact Factor

Publication Analysis

Top Keywords

angiogenesis signaling
12
tyrosine kinases
8
ptprb plcg1
8
signaling genes
8
angiogenesis
5
angiosarcoma
5
negative regulator
4
ptprb negative
4
phosphatase ptprb
4
endothelial phosphatase
4
angiogenesis endothelial
4
regulator vascular
4
growth factor
4
kinases harbored
4
sequencing study
4
factor tyrosine
4
linked angiogenesis
4
vascular growth
4
study somatic
4
secondary angiosarcoma
4

Similar Publications